On March 17 of this year, the Chinese National Medical Products Administration (NMPA) approved the registration application for the innovative product “Disposable Electronic Ureteral Endoscopic Catheter” produced by Beijing Beifang Tengda Technology...
According to research from MyBioGate, in April, the global pharmaceutical industry reached at least 23 transactions, mainly mergers and acquisitions and licensing. M&A transactions mainly occurred between non-Chinese pharmaceutical companies. Two M&As were...
New drug approval: Telitacicept On March 12, the State Food and Drug Administration in China issued an announcement, authorizing conditional approval for RemeGen’s therapeutic biological product for injection, Telitacicept. The drug is an innovative drug TACl-Fc...
EGFR-TKI Lung cancer contributes to the highest number of new and fatal cases of malignant tumors in the world with regards to cancer cases. About 85% of lung cancer cases are non-small cell lung cancer (NSCLC). Most patients with NSCLC often have mutations that lead...
As spring arrived in March, cross-border transactions in the life sciences industry entered an additional month of growth. According to statistics from “Member Capital”, there were 13 Chinese asset licensing in transactions and 4 licensing out transactions...
Recent Comments